Cai Xiaobei, Zhang Youyi, Wang Taoxia, Liu Xiaoli, Cai Xiaofen, Liang Xinyi, Li Guiying
Clinical Medical School, Hebei University of Engineering, Handan, Hebei, China.
Department of Nephrology, The Affiliated Hospital of Hebei Engineering University, The Key Laboratory of Basic Research on Blood Purification Application in Hebei Province, Handan, Hebei, China.
Med Sci Monit. 2025 Jun 24;31:e948127. doi: 10.12659/MSM.948127.
Hemodialysis (HD) is the primary form of renal replacement therapy for renal failure, and autologous arteriovenous fistula (AVF) is the preferred vascular access for long-term hemodialysis. However, AVFs are prone to stenosis during use, leading to fistula dysfunction and failure to meet the high blood flow rates required for dialysis, thereby diminishing the quality of life of patients. Re-interventions following stenosis often fail to address the underlying issues. Therefore, exploring the pathophysiological mechanisms, diagnostic and therapeutic approaches, and preventive measures for AVF stenosis through animal experiments is a crucial scientific endeavor. This review highlights the importance of autologous AVF animal models. The primary focus of this review is to discuss the current situation, ethics, objectives, and requirements of animal experimentation, and to briefly describe the commonly used animals suitable for creating AVF models, surgical methods, and current research outcomes in the scientific community. This article aims to review the role of animal models in studies on autologous arteriovenous fistula for hemodialysis.
血液透析(HD)是肾衰竭患者肾脏替代治疗的主要形式,自体动静脉内瘘(AVF)是长期血液透析的首选血管通路。然而,AVF在使用过程中容易发生狭窄,导致内瘘功能障碍,无法满足透析所需的高血流量,从而降低患者的生活质量。狭窄后的再次干预往往无法解决根本问题。因此,通过动物实验探索AVF狭窄的病理生理机制、诊断和治疗方法以及预防措施是一项至关重要的科学工作。本综述强调了自体AVF动物模型的重要性。本综述的主要重点是讨论动物实验的现状、伦理、目的和要求,并简要描述适合创建AVF模型的常用动物、手术方法以及科学界目前的研究成果。本文旨在综述动物模型在自体动静脉内瘘血液透析研究中的作用。
Vasc Endovascular Surg. 2025-7
Am J Physiol Heart Circ Physiol. 2025-7-1
Cochrane Database Syst Rev. 2022-10-3
Eur J Vasc Endovasc Surg. 2017-5
Arch Ital Urol Androl. 2025-6-30
Mater Today Bio. 2024-6-13
Nat Rev Nephrol. 2024-8
Nat Rev Nephrol. 2024-6
IEEE Trans Biomed Eng. 2024-8